தலை ஆஃப் தகவல் தொழில்நுட்பம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from தலை ஆஃப் தகவல் தொழில்நுட்பம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In தலை ஆஃப் தகவல் தொழில்நுட்பம் Today - Breaking & Trending Today

Angaza Awards unveils the Top 10 women to watch in banking and finance


Shares
The Angaza Awards; Women to Watch in Banking and Finance program has unveiled its list of Top 10 women who are steering and shaping the financial services sector. The list was compiled after a four-month entry period which saw professionals from Kenya, Rwanda, South Sudan, Tanzania and Uganda submit applications.
The Kenyan Wallstreet, a financial news media company partnered with Kaleidoscope Consultants in an effort to raise awareness of seasoned women who are shaping and influencing the sector through their organizations.
The Angaza Award criteria included an assessment of the applicants’ area of responsibility and contribution to firm performance. Professionals in Banking, Capital Markets, Insurance, Investment Banking, Fintech, Fund Management, Microfinance, and SACCOs were invited to submit their applications or nominations via the Kenyan Wallstreet Award Web page. ....

Nairobi Area , South Sudan , Millicent Omukaga , Mary Wamae , Nuru Mugambi , Mary Okello , Catherine Musakali , Luke Ombara , Phyllis Wakiaga , Ester Ndeti , Emmanuella Nzahabonimana , Judith Sidi Odhiambo , Pooja Bhatt , Eric Asuma , Elizabeth Wasunna Ochwa , Catherine Karimi , Joanita Jaggwe , Tabitha Kiriti , Lina Higiro , Head Of Information Technology , University Of Nairobi School Economics , Kenya Women Finance , Angaza Awards Judges Panel , Judges Panel , Group Head Of Corporate Affairs , Bank Rwanda ,

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results


Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2020 Financial Results
March 04, 2021 16:42 ET
| Source:
Cellectis Inc.
Cellectis Inc.
New York, New York, UNITED STATES
Enrollment ongoing in 3 Cellectis-sponsored Phase 1 dose-escalation trials BALLI-01 in r/r B-ALL patients, AMELI-01 in r/r AML patients and MELANI-01 in r/r MM patients in 7 leading US clinical centers
Preliminary results from our Phase 1 BALLI-01 clinical study of UCART22 in adults with r/r B-ALL presented in oral session at 2020 ASH Annual Meeting
Partner Allogene Therapeutics presented initial results from Phase 1 ALPHA clinical study of licensed ALLO-501 in r/r NHL at 2020 ASCO Annual Meeting and from Phase 1 UNIVERSAL clinical study of licensed ALLO-715 in r/r MM at 2020 ASH Annual Meeting ....

United States , New York , France General , North Carolina , Stanford University , Stephan Grupp , Laurent Poirot , Philippe Duchateau , Cytovia Theraputics , Kyung Nam Wortman , Steve Doares , Iovance Biotherapeutics , Simon Harnest , Mark Frattini , Leopold Bertea , Iovance Biotherapeutic , Carrie Brownstein , Jean Pierre Garnier , Margaret Gandolfo , Conor Mcgoldrick , Head Of Information Technology , Calyxt Inc , American Society Of Clinical Oncology , Clinical Development Appointments , Louis Pasteur University Of Strasbourg , Delta Consulting Group ,